Phase I trial of CNV 2197944
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2011
At a glance
- Drugs CNV 2197944 (Primary)
- Indications Musculoskeletal pain; Neuropathic pain
- Focus Adverse reactions; Pharmacokinetics
- 21 Nov 2011 Status changed from recruiting to completed, according to a Convergence Pharmaceuticals media release.
- 21 Apr 2011 Planned End Date changed to 30 Sep 2011, according to a Convergence Pharmaceuticals media release.
- 21 Apr 2011 Status changed from planning to recruiting.